-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Vertex Pharmaceuticals, Lowers Price Target to $415

Benzinga·11/04/2025 16:45:55
Listen to the news
RBC Capital analyst Brian Abrahams maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sector Perform and lowers the price target from $423 to $415.